QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
NASDAQ:TNXP

Tonix Pharmaceuticals - TNXP News Today

$0.57
0.00 (-0.35%)
(As of 10/5/2022 05:45 PM ET)
Add
Compare
Today's Range
$0.56
$0.57
50-Day Range
$0.53
$1.90
52-Week Range
$0.52
$20.00
Volume
763,794 shs
Average Volume
4.63 million shs
Market Capitalization
$25.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.20
Get Tonix Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter.



TNXP Media Mentions By Week

TNXP Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TNXP
News Sentiment

1.11

0.80

Average
Medical
News Sentiment

TNXP News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TNXP Articles
This Week

1

1

TNXP Articles
Average Week

SourceHeadline
finance.yahoo.com logoTonix Pharmaceuticals Announces IND Clearance for TNX-601 ER as a Potential Treatment for Major Depressive Disorder
finance.yahoo.com - October 3 at 8:24 AM
finance.yahoo.com logoTonix Pharmaceuticals Presents Data from Retrospective Observational Database Study on the Incidence of Multi-Site Pain Symptoms in Long COVID Patients at IASP 2022 World Congress on Pain
finance.yahoo.com - September 22 at 7:34 AM
finance.yahoo.com logoTonix Pharmaceuticals Announces Data Presentations Involving TNX-1500 (Fc-Modified Anti-CD40L mAb) for the Prevention of Rejection in Allograft and Xenograft Transplantation in Animal Models at the International Congress of The Transplantation Society (TTS 2022)
finance.yahoo.com - September 15 at 8:32 AM
finance.yahoo.com logoTonix Pharmaceuticals Holding Corp. (TNXP)
finance.yahoo.com - September 11 at 10:42 PM
msn.com logoLooking Into Tonix Pharmaceuticals's Recent Short Interest
msn.com - August 23 at 5:02 PM
msn.com logoTonix Pharmaceuticals Commences Mid-Stage Long COVID Study, Sees Interim Report In H1 2023
msn.com - August 22 at 9:13 AM
proactiveinvestors.com logoTonix Pharmaceuticals prepares to tackle monkeypox outbreak with TNX-801 vaccine
proactiveinvestors.com - August 11 at 5:47 PM
finance.yahoo.com logoTonix Pharmaceuticals Receives Federal Grant from the National Institute on Drug Abuse (NIDA) to Advance Development of TNX-1300 as a Treatment for Cocaine Intoxication
finance.yahoo.com - August 2 at 8:04 AM
benzinga.com logoTonix Pharmaceuticals Announces Issuance of U.S. Patent Covering Potentiated Intranasal Oxytocin (TNX-1900) for the Treatment of Pain
benzinga.com - August 1 at 7:07 AM
finance.yahoo.com logoTonix Pharmaceuticals Announces Collaboration with Kenya Medical Research Institute to Develop TNX-801 in Kenya as a Vaccine for the Prevention of Monkeypox and Smallpox Infection
finance.yahoo.com - July 28 at 7:54 AM
finance.yahoo.com logoSiga, Peers Rise on Optimism Over Monkeypox Therapies
finance.yahoo.com - July 25 at 8:21 PM
finance.yahoo.com logoTonix Pharmaceuticals Announces Development of TNX-601 ER, a Potential Abuse Deterrent, Extended-Release Formulation of Tianeptine Oxalate for the Treatment of Major Depressive Disorder
finance.yahoo.com - July 11 at 9:31 AM
finance.yahoo.com logoTonix Pharmaceuticals Announces Presentation at the World Orphan Drug Congress USA
finance.yahoo.com - July 6 at 8:44 AM
finance.yahoo.com logoNew to The Street TV / Newsmax TV Announces its Six Interviews for This Week's TV Broadcast, Episode #358, June 26, 2022, 10-11 AM ET
finance.yahoo.com - June 24 at 10:01 AM
seekingalpha.com logoIs Tonix Pharma's Stock A Buy Or Sell After Buyback Plan Announcement?
seekingalpha.com - June 21 at 9:13 AM
finance.yahoo.com logoMarket check: Stocks pare gains following Fed rate hike
finance.yahoo.com - June 15 at 3:07 PM
finance.yahoo.com logoTonix Pharmaceuticals Announces Presentation at the 2022 BIO International Convention
finance.yahoo.com - June 6 at 7:11 AM
finance.yahoo.com logoBioMed Stocks On the Move: PDSB, NMLSF, TNXP, AIMLF; Leaders Report Latest Advances in Antiviral Vaccines, Novel Therapeutics for Oncology, and Autism and HealthTech Wearables
finance.yahoo.com - June 2 at 4:07 PM
markets.businessinsider.com logoMid-Day Market Update: Dow Dips 200 Points; Tonix Pharmaceuticals Shares Spike Higher
markets.businessinsider.com - June 1 at 6:20 PM
finance.yahoo.com logoTonix's stock jumps 43% on patent for experimental pox vaccines
finance.yahoo.com - June 1 at 6:20 PM
benzinga.com logoMid-Morning Market Update: Markets Mixed; ISM Manufacturing PMI Rises To 56.1 In May
benzinga.com - June 1 at 10:34 AM
nasdaq.com logoPre-market Movers: TNXP, CNCE, TXMD, JAN, BFI…
nasdaq.com - June 1 at 8:39 AM
finance.yahoo.com logoTonix Pharmaceuticals Announces Two Oral Presentations Involving TNX-1500 (Fc-modified anti-CD40L mAb) on Prevention of Rejection in Kidney and Heart Allograft Transplantation at the 2022 American Transplant Congress
finance.yahoo.com - May 31 at 9:53 AM
finance.yahoo.com logoNew to The Street TV / Newsmax TV announces its 348th Episode with Seven Interviews on This Week’s TV Broadcast, Airing May 29, 2022, 10-11 AM ET
finance.yahoo.com - May 27 at 1:43 PM
fool.com logoWhy Tonix Pharmaceuticals Continued to Plummet Today
fool.com - May 18 at 5:29 PM
seekingalpha.com logoTonix Pharmaceuticals stock slumps ~21% on eve of 1-for-32 reverse stock split
seekingalpha.com - May 16 at 3:40 PM
finance.yahoo.com logoTonix Pharmaceuticals Announces 1-for-32 Reverse Stock Split
finance.yahoo.com - May 16 at 3:40 PM
finance.yahoo.com logoNew to The Street TV announces its 345th Episode, Airing Four Corporate Interviews, on the Fox Business Network, Tonight, Monday, May 16, 2022, at 10:30 PM PT
finance.yahoo.com - May 16 at 10:39 AM
finance.yahoo.com logoTonix Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Highlights
finance.yahoo.com - May 9 at 9:26 AM
benzinga.com logoAt Tonix, History Underpins a Modern Approach to COVID-19 Vaccines
benzinga.com - May 5 at 6:58 PM
finance.yahoo.com logoTonix Pharmaceuticals to Participate in the NobleCon18 Investor Conference
finance.yahoo.com - April 12 at 8:58 AM
finance.yahoo.com logoTonix Pharma Starts New Pivotal Trial For TNX-102 SL In Fibromyalgia Patients
finance.yahoo.com - April 7 at 4:01 PM
finance.yahoo.com logoTonix Pharmaceuticals Initiates Enrollment in the RESILIENT Study, a Potentially Pivotal Phase 3 Study of TNX-102 SL for the Management of Fibromyalgia
finance.yahoo.com - April 7 at 10:03 AM
seekingalpha.com logoTonix Pharma wins FDA clearance for Long COVID trial
seekingalpha.com - April 6 at 9:28 AM
nasdaq.com logoTonix Pharma Gets IND Clearance To Begin Clinical Trials Of TNX-102 SL In Treatment Of Long COVID
nasdaq.com - April 6 at 9:28 AM
finance.yahoo.com logoTonix Pharmaceuticals Announces IND Clearance for TNX-102 SL as a Potential Treatment for Long COVID Syndrome, Also Known as Post-Acute Sequelae of COVID-19 (PASC)
finance.yahoo.com - April 6 at 9:28 AM
seekingalpha.com logoTonix Pharma to develop live-virus vaccine against COVID-19 with Kansas State University
seekingalpha.com - April 5 at 1:15 PM
finance.yahoo.com logoTonix Pharmaceuticals Announces Extension of Sponsored Research Agreement with Kansas State University to Develop Live-Virus Vaccine Against COVID-19
finance.yahoo.com - April 5 at 8:14 AM
finance.yahoo.com logoTNXP: Targeting Organ Transplant Rejection with TNX-1500; Phase 1 Trial to Initiate 2H22…
finance.yahoo.com - March 31 at 3:10 PM
benzinga.com logoExecutives Buy More Than $1M Of 5 Penny Stocks
benzinga.com - March 29 at 2:33 PM
proactiveinvestors.com logoTonix Pharmaceuticals CEO talks through 2021 highlights, ending year with $179M in cash
proactiveinvestors.com - March 25 at 5:54 PM
finance.yahoo.com logoTonix Pharmaceuticals to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest
finance.yahoo.com - March 22 at 7:13 AM
seekingalpha.com logoTonix Pharma says late-stage trial for fibromyalgia candidate did not reach main goal
seekingalpha.com - March 21 at 10:18 AM
finance.yahoo.com logoTonix Pharmaceuticals Announces Phase 3 RALLY Study Results for TNX-102 SL 5.6 mg for the Management of Fibromyalgia
finance.yahoo.com - March 21 at 10:18 AM
benzinga.com logoTonix Pharmaceuticals: Q4 Earnings Insights
benzinga.com - March 14 at 8:35 AM
finance.yahoo.com logoMarket check: S&P 500 on track for best day since May 2020
finance.yahoo.com - March 9 at 4:16 PM
uk.investing.com logoKohl's Plans To Open New Smaller Format Stores, Grow Sephora Business
uk.investing.com - March 7 at 11:55 AM
fool.com logoWhy Tonix Pharmaceuticals Rocketed 33% Higher Today
fool.com - March 3 at 7:35 PM
finance.yahoo.com logoTonix Pharma Inks Research Pact For Oxytocin In Eating Disorder
finance.yahoo.com - February 28 at 3:02 PM
finance.yahoo.com logoNew to The Street TV Announces its Line-ups Airing on the Fox Business Network, Episode #308, Tonight Monday, February 21, 2022, 10:30 PM PT and Episode #309, Tomorrow Night, Tuesday, February 22, 2022, 10:30 PM PT
finance.yahoo.com - February 21 at 11:22 AM
Get Tonix Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:TNXP) was last updated on 10/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.